A double-blind, controlled, clinical trial of spironolactone for benign prostatic hypertrophy.
D002986:Clinical Trials as Topic; D003558:Cystoscopy; D005163:Factor Analysis, Statistical; D006801:Humans; D008297:Male; D010919:Placebos; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D013148:Spironolactone / Q000627:therapeutic use*; D014508:Urea / Q000097:blood; D014546:Urinary Catheterization; D014556:Urine / Q000382:microbiology; D014567:Urography
D010919:Placebos; D013148:Spironolactone; D014508:Urea